Therefore, IS not only impairs EPO signaling but also interferes with erythroid maturation and survival, compounding the challenge of managing anemia and potentially blunting the beneficial cellular effects of ESAs in CKD. The gene discussed is EPO; the disease is chronic kidney disease.